Homocysteine and dementia: an international consensus statement
Manuscript Number:
17-1042R2
Author(s):
Teodoro Bottiglieri, Michael F. Fenech, Babak Hooshmand, Andrew McCaddon, Joshua W. Miller, Rima Obeid, Helga Refsum, Irwin H. Rosenberg, A. David Smith
Disclosures
Teodoro Bottiglieri
Consulting Fees:
Paid advisory board member for Merck
Lecture Fees:
Received lecture fees from Gnosis S.p.A.
Michael F. Fenech
Consulting Fees:
Expert Panel member of research foundations. $US1000-$US5,000
Lecture Fees:
Invited lectures on micronutrients for DNA damage prevention. $US1,000-$US5,000.
Grants
Agency:
Dairy Research Council USA
Dates:
2015-2016
Babak Hooshmand
Nothing to Disclose
Andrew McCaddon
Equity:
Shareholder of COBALZ Limited, a private limited company developing novel B vitamin supplements.
Patents/Royalties
Inventor of US patent 7,709,460 "Method for treating or preventing a functional vitamin B12 deficiency in an individual and medical compositions for use in said method," and in receipt of royalties from its license to Alfa-Sigma.
Joshua W. Miller
Nothing to Disclose
Rima Obeid
Lecture Fees:
lecture fees Synlab GmbH (1000 Euro)
Helga Refsum
Consulting Fees:
I consult for Merck Selbstmedikation GmbH, Darmstadt
Patents/Royalties
I am named as inventor on patent US9364497B2 and on a patent application pending PCT/GB2015/050786
Irwin H. Rosenberg
Equity:
13,000 shares in AC Immune
A. David Smith
Consulting Fees:
Dr Smith consults for Merck Selbstmedikation GmbH and in the past for Nestle Health Sciences
Lecture Fees:
A single KeyNote lecture in Melbourne on Nutrition and Alzheimer's disease for Swisse
Patents/Royalties
Dr Smith is named as inventor on patents US6008221, US6127370 and US9364497B2 and on a patent application pending PCT/GB2015/050786